340B Hospitals Should Consider Internal Pharmacies, Selective Contracting, Says Consulting Group

Executives at a healthcare financial consulting group recommended 340B hospitals consider using in-house pharmacies.
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CVS Cites 340B Contract Pharmacy Restrictions in 19% Income Drop in Its Pharmacy Services

CVS Health said drugmaker 340B contract pharmacy restrictions contributed to a decline in the company's pharmacy services revenue.
CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Consulting Firm Visante Garners PE Investment, Makes Several Promotions

Steve Rough, the new CEO of Visante, said the health system consulting firm has received its first private equity investment.
Health system consulting firm Visante on Monday received a first-ever investment from a private equity firm and undertook planned changes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Legislation ‘Is Coming’ to Address Contract Pharmacy Restrictions, Hospital Advocate Says

Maureen Testoni headshot
Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Report Bolsters Editorial Staff with Two Key Hires

Rich and Will
Rich Daly (left) is 340B Report's new editor in chief and Will Newton is its new Washington correspondent. Tom Mirga, top editor since its founding in 2020, is now editor at large.

340B Report, the indispensable source for news and intelligence on the 340B drug pricing program, has added two team members with deep health care journalism experience. Rich Daly, a veteran healthcare business and policy journalist, is 340B Report’s new editor

Read More »

Get PBMs to Squeeze 340B Drugs Harder, “Playbook” Advises Employers

NAHPC
A new "playbook" for business-sponsored health plans advises them to press PBMs to do more to ensure that health care purchasers get the benefits of 340B drug discounts.

A new “playbook” for employers on getting the upper hand with pharmacy benefit managers says PBM handling of 340B drugs is a top 10 concern for business-sponsored health plans.

Released yesterday by the Washington, D.C., based National Alliance of Healthcare

Read More »

Sean Dickson, Known for 340B Research, Takes Senior Post at Health Insurance Association

Sean Dickson headshot
Sean Dickson, a drug policy expert who has published frequently cited research on 340B, has gone to work for the health insurance industry.

Sean Dickson, a drug policy expert who has published frequently cited research on the 340B program and advised both health care providers and drug manufacturers on 340B compliance, has gone to work for the health insurance industry.

Dickson, most recently

Read More »

340B Market News: Avita Acquires PrEP-by-Telehealth Provider Q Care Plus

QCare+ wordmark
340B contract pharmacy and third-party administration services company Avita has acquired Q Care Plus, a business that helps patients access PrEP by telehealth.

Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, has acquired Q Care Plus, a business that helps patients access HIV pre-exposure prophylaxis (PrEP) medication by telehealth.

PMQ Investors LLC, Avita’s

Read More »

Kalderos Announces New 340B Drug Claims Verification Tool

Kalderos Discount Hub logo
Kalderos has replaced its Review 340B claims verification tool with a new one named Discount Hub.

Pharmaceutical manufacturer contractor Kalderos has replaced Review, its 340B drug claims verification tool, with a new one named Discount Hub.

Chicago-based Kalderos announced the change in an Aug. 31 blog post and an Oct. 12 news release. It said Discount Hub

Read More »

340B Pharmacy Services Company Avita Expands into Clinician and Support Staff Services

Michael Yount, Avita headshot
Maintaining regular access to providers is a challenge for many 340B grantee entities and can make it hard for them to leverage the 340B program, Avita CEO Michael Yount says.

Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, is expanding into medical practice staffing and management.

Avita announced Oct. 5 that it has acquired HIV/AIDS, LGBTQ+, and primary care health

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live